New! View global litigation for patent families

US20040102839A1 - Method and apparatus for improving mitral valve function - Google Patents

Method and apparatus for improving mitral valve function Download PDF

Info

Publication number
US20040102839A1
US20040102839A1 US10607366 US60736603A US2004102839A1 US 20040102839 A1 US20040102839 A1 US 20040102839A1 US 10607366 US10607366 US 10607366 US 60736603 A US60736603 A US 60736603A US 2004102839 A1 US2004102839 A1 US 2004102839A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
mitral
coronary
sinus
body
leaflet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10607366
Inventor
William Cohn
John Liddicoat
Steven Woolfson
Richard Streeter
Original Assignee
Cohn William E.
Liddicoat John R.
Woolfson Steven B.
Streeter Richard B.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2451Inserts in the coronary sinus for correcting the valve shape
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/902Method of implanting
    • Y10S623/904Heart

Abstract

A method and apparatus for reducing mitral regurgitation. The apparatus is inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being configured to straighten the natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation and reduce mitral regurgitation.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • [0001]
    This patent application:
  • [0002]
    (1) claims benefit of pending prior U.S. Patent Application Serial No. 60/391,790, filed Jun. 26, 2002, by William E. Cohn et al. for METHOD AND APPARATUS FOR IMPROVING MITRAL VALVE FUNCTION (Attorney's Docket No. VIA-34 PROV); and
  • [0003]
    (2) is a continuation-in-part of pending prior U.S. patent application Ser. No. 10/446,470, filed May 27, 2003, by Jonathan M. Rourke et al. for METHOD AND APPARATUS FOR IMPROVING MITRAL VALVE FUNCTION (Attorney's Docket No. VIA 43);
  • [0004]
    which are incorporated herein by reference.
  • FIELD OF THE INVENTION
  • [0005]
    This invention relates to surgical methods and apparatus in general, and more particularly to surgical methods and apparatus for improving mitral valve function.
  • BACKGROUND OF THE INVENTION
  • [0006]
    Mitral valve repair is the procedure of choice to correct mitral regurgitation of all etiologies. With the use of current surgical techniques, between 70% and 95% of regurgitant mitral valves can be repaired. The advantages of mitral valve repair over mitral valve replacement are well documented. These include better preservation of cardiac function and reduced risk of anticoagulant-related hemorrhage, thromboembolism and endocarditis.
  • [0007]
    In current practice, mitral valve surgery requires an extremely invasive approach that includes a chest wall incision, cardiopulmonary bypass, cardiac and pulmonary arrest, and an incision on the heart itself to gain access to the mitral valve. Such a procedure is associated with high morbidity and mortality. Due to the risks associated with this procedure, many of the sickest patients are denied the potential benefits of surgical correction of mitral regurgitation. In addition, patients with moderate, symptomatic mitral regurgitation are denied early intervention and undergo surgical correction only after the development of cardiac dysfunction.
  • [0008]
    Mitral regurgitation is a common occurrence in patients with heart failure and a source of important morbidity and mortality in these patients. Mitral regurgitation in patients with heart failure is caused by changes in the geometric configurations of the left ventricle, papillary muscles and mitral annulus. These geometric alterations result in incomplete coaptation of the mitral leaflets at systole. In this situation, mitral regurgitation is corrected by plicating the mitral valve annulus, either by sutures alone or by sutures in combination with a support ring, so as to reduce the circumference of the distended annulus and restore the original geometry of the mitral valve annulus.
  • [0009]
    More particularly, current surgical practice for mitral valve repair generally requires that the mitral valve annulus be reduced in radius by surgically opening the left atrium and then fixing sutures, or more commonly sutures in combination with a support ring, to the internal surface of the annulus; this structure is used to cinch the annulus, in a pursestring-like fashion, to a smaller radius, thereby reducing mitral regurgitation by improving leaflet coaptation.
  • [0010]
    This method of mitral valve repair, generally termed “annuloplasty”, effectively reduces mitral regurgitation in heart failure patients. This, in turn, reduces symptoms of heart failure, improves quality of life and increases longevity. Unfortunately, however, the invasive nature of mitral valve surgery and the attendant risks render most heart failure patients poor surgical candidates. Thus, a less invasive means to increase leaflet coaptation and thereby reduce mitral regurgitation in heart failure patients would make this therapy available to a much greater percentage of patients.
  • [0011]
    Mitral regurgitation also occurs in approximately 20% of patients suffering acute myocardial infarction. In addition, mitral regurgitation is the primary cause of cardiogenic shock in approximately 10% of patients who develop severe hemodynamic instability in the setting of acute myocardial infarction. Patients with mitral regurgitation and cardiogenic shock have about a 50% hospital mortality. Elimination of mitral regurgitation in these patients would be of significant benefit. Unfortunately, however, patients with acute mitral regurgitation complicating acute myocardial infarction are particularly high-risk surgical candidates, and are therefore not good candidates for a traditional annuloplasty procedure. Thus, a minimally invasive means to effect a temporary reduction or elimination of mitral regurgitation in these critically ill patients would afford them the time to recover from the myocardial infarction or other acute life-threatening events and make them better candidates for medical, interventional or surgical therapy.
  • SUMMARY OF THE INVENTION
  • [0012]
    As a result, one object of the present invention is to provide an improved method and apparatus for reducing mitral regurgitation.
  • [0013]
    Another object of the present invention is to provide a method and apparatus for reducing mitral regurgitation which is minimally invasive.
  • [0014]
    Another object of the present invention is to provide a method and apparatus for reducing mitral regurgitation which can be deployed either permanently (e.g., for patients suffering from heart failure) or temporarily (e.g., for patients suffering from mitral regurgitation with acute myocardial infarction).
  • [0015]
    These and other objects are addressed by the present invention, which comprises an improved method and apparatus for reducing mitral regurgitation.
  • [0016]
    In one form of the invention, there is provided a method for reducing mitral regurgitation comprising:
  • [0017]
    inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being adapted to straighten the natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
  • [0018]
    In another form of the invention, there is provided a method for reducing mitral regurgitation comprising:
  • [0019]
    inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being adapted to move at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve anteriorly, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
  • [0020]
    In another form of the invention, there is provided a method for reducing mitral regurgitation comprising:
  • [0021]
    inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being adapted to reduce the degree of natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
  • [0022]
    In another form of the invention, there is provided a method for reducing mitral regurgitation comprising:
  • [0023]
    inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being adapted to increase the natural radius of curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
  • [0024]
    In another form of the invention, there is provided a method for reducing mitral regurgitation comprising:
  • [0025]
    inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus having a distal end, a proximal end and an intermediate portion, the apparatus being configured so that when the apparatus is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends apply a posteriorly-directed force to the wall of the coronary sinus and the intermediate portion applies an anteriorly-directed force to the wall of the coronary sinus, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
  • [0026]
    In another form of the invention, there is provided a method for reducing mitral regurgitation comprising:
  • [0027]
    inserting a substantially straight elongated body into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the substantially straight elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially straight elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mitral annulus and thereby improve leaflet coaptation.
  • [0028]
    In another form of the invention, there is provided a method for reducing mitral regurgitation comprising:
  • [0029]
    inserting a substantially rigid elongated body into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the substantially rigid elongated body being configured relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially rigid elongated body is positioned in the coronary sinus, it causes at least a portion of the coronary sinus to assume a different configuration adjacent to the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
  • [0030]
    In another form of the invention, there is provided a method for reducing mitral regurgitation comprising:
  • [0031]
    inserting a straight, substantially rigid elongated body into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the straight, substantially rigid elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the straight, substantially rigid elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mitral annulus and thereby improve leaflet coaptation.
  • [0032]
    In another form of the invention, there is provided an apparatus for reducing mitral regurgitation comprising:
  • [0033]
    a body having a distal end, a proximal end and an intermediate portion, the body being configured so that when the body is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends apply a posteriorly-directed force to the wall of the coronary sinus, and the intermediate portion applies an anteriorly-directed force to the wall of the coronary sinus, whereby to move the posterior annulus of the mitral valve anteriorly and thereby improve leaflet coaptation.
  • [0034]
    In another form of the invention, there is provided an apparatus for reducing mitral regurgitation comprising:
  • [0035]
    a substantially straight elongated body adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the substantially straight elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially straight elongated body is positioned in the coronary sinus, it causes at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mitral annulus, moving it anteriorly, and thereby improve leaflet coaptation.
  • [0036]
    In another form of the invention, there is provided an apparatus for reducing mitral regurgitation comprising:
  • [0037]
    a substantially rigid elongated body adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the straight, substantially rigid elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially rigid elongated body is positioned in the coronary sinus, it causes at least a portion of the coronary sinus to assume a different configuration adjacent to the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
  • [0038]
    In another form of the invention, there is provided an apparatus for reducing mitral regurgitation comprising:
  • [0039]
    a straight, substantially rigid elongated body adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the straight, substantially rigid elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the straight, substantially rigid elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mitral annulus, moving it anteriorly, and thereby improve leaflet coaptation.
  • [0040]
    In accordance with a further feature of the present invention, there is provided a catheter comprising a flexible elongated delivery tube having a central lumen extending from a distal end of the tube to a proximal end of the tube, the flexibility of the tube being such as to permit closure of the distal end of the tube upon encounter with an impinging body structure, whereby to inhibit flow of fluid out of the distal end of the tube. Orifice means defined by the tube are disposed in a side wall thereof, the orifice means being disposed proximate but spaced from the distal end of the tube and configured to permit egress of fluid from the tube.
  • [0041]
    In accordance with a further feature of the invention, there is provided a catheter comprising a flexible elongated delivery tube having a central lumen extending from a distal end of the tube to a proximal end of the tube, and longitudinally extending surface grooves disposed in an outer surface of the tube to permit flow of fluid longitudinally of the tube.
  • [0042]
    In accordance with a still further feature of the invention, there is provided an apparatus for reducing mitral regurgitation. The apparatus comprises a body having a distal end, a proximal end, and an intermediate portion, the body being configured such that when the body is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends apply a posteriorly-directed force to the wall of the coronary sinus, and the intermediate portion applies an anteriorly-directed force to the wall of the coronary sinus, whereby to move the posterior annulus of the mitral valve anteriorly and thereby improve leaflet coaptation. Longitudinally extending surface grooves are disposed in an outer surface of the body to permit flow of fluid longitudinally of the body.
  • [0043]
    Significantly, the present invention may be practiced in a minimally invasive manner, either permanently or temporarily, so as to reduce mitral regurgitation.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0044]
    These and other objects and features of the present invention will be more fully disclosed or rendered obvious by the following detailed description of the preferred embodiments of the invention, which is to be considered together with the accompanying drawings wherein like numbers refer to like parts and further wherein:
  • [0045]
    [0045]FIG. 1 is a schematic view of portions of the human vascular system;
  • [0046]
    [0046]FIG. 2 is a schematic view of portions of the human heart;
  • [0047]
    [0047]FIG. 3 is a schematic view of a preferred system formed in accordance with the present invention;
  • [0048]
    FIGS. 4-7 are a series of views illustrating use of the system of FIG. 3 to reduce mitral regurgitation;
  • [0049]
    [0049]FIG. 8 shows an alternative form of delivery catheter;
  • [0050]
    [0050]FIG. 9 shows an alternative form of flexible push rod;
  • [0051]
    [0051]FIG. 9A shows another alternative form of the present invention;
  • [0052]
    [0052]FIGS. 10 and 11 show alternative constructions for the straight, substantially rigid elongated body;
  • [0053]
    [0053]FIG. 12 shows an alternative system formed in accordance with the present invention;
  • [0054]
    [0054]FIG. 13 shows use of the system shown in FIG. 12;
  • [0055]
    [0055]FIG. 14 is a schematic view of a known catheter shown being used in the introduction of a substantially straight, substantially rigid elongated body into place to reduce mitral regurgitation, and encountering a common problem;
  • [0056]
    [0056]FIG. 15 is a schematic view similar to FIG. 14 but illustrating an alternative catheter providing a solution to the aforesaid problem;
  • [0057]
    [0057]FIG. 16 is an enlarged sectional view of a portion of the catheter of FIG. 15;
  • [0058]
    [0058]FIG. 17 is a side elevational view of a further alternative catheter;
  • [0059]
    [0059]FIG. 18 is a sectional view taken along line XVIII-XVIII of FIG. 17;
  • [0060]
    [0060]FIG. 19 is a side elevational view of a still further alternative catheter; and
  • [0061]
    [0061]FIG. 20 is a sectional view taken along line XX-XX of FIG. 19.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • [0062]
    The coronary sinus is the largest vein in the human heart. During a large portion of its course in the atrioventricular groove, the coronary sinus typically extends adjacent to the left atrium of the heart for a distance of approximately 5 to 10 centimeters. Significantly, for a portion of its length, e.g., typically approximately 7-9 cm, the coronary sinus extends substantially adjacent to the posterior perimeter of the mitral annulus. The present invention takes advantage of this fact. More particularly, by deploying novel apparatus in the coronary sinus, adjacent to the posterior leaflet of the mitral valve, the natural curvature of the coronary sinus may be modified in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly so as to improve leaflet coaptation and, as a result, reduce mitral regurgitation.
  • [0063]
    In one preferred embodiment of the invention, the novel apparatus comprises a straight, substantially rigid elongated body, the length of the straight, substantially rigid elongated body being sized so that when the straight, substantially rigid body is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the straight, substantially rigid elongated body will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
  • [0064]
    And in one preferred embodiment of the invention, access to the coronary sinus is gained percutaneously, e.g., the straight, substantially rigid elongated body is introduced into the patient's vascular system via the jugular vein or via the left subclavian vein, passed down the superior vena cava, passed through the right atrium and then passed into the coronary sinus, where it is deployed. Alternatively, the straight, substantially rigid elongated body may be introduced into the coronary sinus through a small incision in the heart, or through some other incision into the patient's vascular system.
  • [0065]
    And in one preferred embodiment of the invention, the straight, substantially rigid elongated body is guided into position by (i) passing it through a pre-positioned catheter, or (ii) passing it over a pre-positioned guidewire, or (iii) passing it guide-free (e.g., on the end of a steerable delivery tool) to the surgical site.
  • [0066]
    Once deployed, the novel apparatus may be left in position permanently (e.g., in the case of patients suffering from mitral regurgitation associated with heart failure) or the novel apparatus may be left in position only temporarily (e.g., in the case of patients suffering from mitral regurgitation associated with acute myocardial infarction).
  • [0067]
    Visualization of the procedure may be obtained by fluoroscopy, echocardiography, intravascular ultrasound, angioscopy, real-time magnetic resonance imaging, etc. The efficacy of the procedure may be determined through echocardiography, although other imaging modalities may also be suitable.
  • [0068]
    Looking now at FIG. 1, there are shown aspects of the cardiovascular system 3 of a patient. More particularly, cardiovascular system 3 generally comprises the heart 6, the superior vena cava 9, the right subclavian vein 12, the left subclavian vein 15, the jugular vein 18, and the inferior vena cava 21. Superior vena cava 9 and inferior vena cava 21 communicate with the heart's right atrium 24. The coronary ostium 27 leads to coronary sinus 30. At the far end 31 (FIG. 2) of coronary sinus 30, the vascular structure turns into the vertically-descending anterior interventricular vein (“AIV”) 32 (see FIG. 1). For purposes of the present invention, it can generally be convenient to consider the term “coronary sinus” to mean the vascular structure extending between coronary ostium 27 and AIV 32.
  • [0069]
    As seen in FIG. 2, between coronary ostium 27 and AIV 32, coronary sinus 30 generally extends substantially adjacent to the posterior perimeter of the annulus 33 of the mitral valve 36. Mitral valve 36 comprises a posterior leaflet 39 and an anterior leaflet 42. In the case of a regurgitant mitral valve, posterior leaflet 39 and anterior leaflet 42 will generally fail to properly coapt at systole, thereby leaving an intervening gap 45 which will permit regurgitation.
  • [0070]
    Looking next at FIG. 3, there is shown a system 100 which comprises one preferred embodiment of the present invention. More particularly, system 100 generally comprises a guidewire 103, a delivery catheter 106 and a push rod 109.
  • [0071]
    Guidewire 103 comprises a flexible body 112 having a distal end 115 and a proximal end 118. The distal end 115 of guidewire 103 preferably includes a spring tip 121 for allowing the distal end of guidewire 106 to atraumatically traverse vascular structures, i.e., while the guidewire is being passed through the vascular system of a patient.
  • [0072]
    Delivery catheter 106 comprises a flexible body 124 having a distal end 127 and a proximal end 130, preferably with an adjustable valve 133 attached. A central lumen 136 extends from distal end 127 to proximal end 130. In some circumstances it may be desirable to provide a securing mechanism for securing the distal end of the delivery catheter within a vascular structure. By way of example but not limitation, a balloon 139 may be positioned about the exterior of flexible body 124, just proximal to distal end 127, with an inflation lumen 142 extending between balloon 139 and an inflation fitting 145.
  • [0073]
    Push rod 109 comprises a flexible body 148 having a distal end 151 and a proximal end 154. A straight, substantially rigid elongated body 157, which may have a variety of different lengths, is formed on flexible body 148, proximal to distal end 151. A removable proximal stiffener or handle 160 may be placed between straight, substantially rigid elongated body 157 and proximal end 154.
  • [0074]
    System 100 may be used as follows to reduce mitral regurgitation.
  • [0075]
    First, distal end 115 of guidewire 103 is passed down the jugular vein 18 (or the left subclavian vein 15) of a patient, down superior vena cava 9, through right atrium 24 of the heart, and then into coronary sinus 30. See FIG. 4. It will be appreciated that as flexible guidewire 103 is passed down coronary sinus 30, the guidewire will tend to assume the natural curved shape of the coronary sinus, due to the flexible nature of the guidewire. The guidewire's atraumatic spring tip 121 will help ensure minimal damage to vascular structures as guidewire 103 is maneuvered into position.
  • [0076]
    Next, distal end 127 of delivery catheter 106 is placed over proximal end 118 of guidewire 103 and passed down the guidewire until the distal end of the delivery catheter is positioned in coronary sinus 30. See FIG. 5. Again, it will be appreciated that as the flexible delivery catheter 106 passes down the coronary sinus, the delivery catheter will tend to assume the natural curved shape of the coronary sinus, due to the flexible nature of the delivery catheter.
  • [0077]
    Once delivery catheter 106 has been positioned within the coronary sinus, guidewire 103 is removed. See FIG. 6. Either before or after guidewire 103 is removed, balloon 139 may be inflated so as to secure distal end 127 of delivery catheter 106 in position within coronary sinus 30.
  • [0078]
    Next, push rod 109 is passed down the central lumen 136 of delivery catheter 106. As the push rod's straight, substantially rigid elongated body 157 is passed down central lumen 136 of delivery catheter 106, it will force the delivery catheter to assume a straight configuration at the point where the straight, substantially rigid elongated body 157 currently resides. As push rod 109 is pushed down delivery catheter 106, balloon 139 will hold the distal end of the delivery catheter in position within coronary sinus 30.
  • [0079]
    Push rod 109 is pushed down delivery catheter 106, utilizing removable proximal stiffener 160 as needed, until the straight, substantially rigid elongated body 157 is located adjacent to the posterior annulus of mitral valve 36. See FIG. 7. As this occurs, the presence of the straight, substantially rigid elongated body 157 in delivery catheter 106 will cause at least a portion of coronary sinus 30 to assume a substantially straight configuration at this point, so that the posterior annulus of mitral valve 36 is forced anteriorly. This will cause the mitral valve's posterior leaflet 39 to also move anteriorly so as to improve mitral valve leaflet coaptation and thereby reduce (or completely eliminate) mitral valve regurgitation. In this respect it should be appreciated that the posterior annulus may be shifted anteriorly so as to achieve, or to attempt to achieve to the extent anatomically possible, leaflet-to-leaflet engagement or leaflet-to-annulus engagement (e.g., where a leaflet may be tethered due to left ventricular distortion). Both of these types of engagement, or targeted engagement, are intended to be encompassed by the terms “improved leaflet coaptation” and/or “increased leaflet coaptation” and the like. Using standard visualization means (e.g. echocardiography or fluoroscopy), the exact position of the straight, substantially rigid elongated body 157 is adjusted so as to reduce (or completely eliminate) regurgitation in mitral valve 36.
  • [0080]
    In this respect it should be appreciated that the straight, substantially rigid elongated body 157 is preferably sized to be somewhat less than the length of the coronary sinus between coronary ostium 27 and AIV 32. However, in some circumstances it may be desirable to size the straight, substantially rigid elongated body 157 so that it will extend out of the coronary sinus and into the right atrium.
  • [0081]
    Furthermore, it should also be appreciated that the system provides a degree of tactile feedback to the user during deployment. More particularly, substantial resistance will typically be encountered as the straight, substantially rigid elongated body 157 is pushed out of right atrium 24 and into coronary sinus 30; then resistance will typically drop as body 157 is moved through the coronary sinus; and then resistance will typically increase significantly again as the distal tip of body 157 comes to the far end 31 of the coronary sinus. Thus, there is a sort of tactile “sweet spot” when the straight, substantially rigid elongated body 157 is located in the coronary sinus between coronary ostium 27 and AIV 32, and this tactile “sweet spot” can be helpful to the user in positioning the straight, substantially rigid elongated body 157 in coronary sinus 30.
  • [0082]
    At this point the straight, substantially rigid elongated body 157 is locked in position, e.g., by closing an adjustable valve 133, and balloon 139 may be deflated.
  • [0083]
    System 100 is left in this position until it is no longer needed. In some cases this may mean that system 100 is left in position for a period of a few hours, days or weeks; in other cases system 100 may be substantially permanent. If and when system 100 is to be removed, push rod 109 is removed from delivery catheter 106, and then delivery catheter 106 is removed from the patient.
  • [0084]
    Thus it will be seen that with the present invention, the straight, substantially rigid elongated body 157 is essentially force-fit into the normally curved portion of the coronary sinus adjacent to the mitral valve's posterior leaflet. By properly sizing the length of the straight, substantially rigid elongated body 157 relative to the natural curvature of the patient's anatomy, and by properly positioning the straight, substantially rigid elongated body 157 in the patient's coronary sinus, the straight, substantially rigid elongated body will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve. This action will in turn drive the posterior annulus of the mitral valve anteriorly, so as to improve leaflet coaptation and thereby reduce mitral regurgitation. Thus, by inserting the straight, substantially rigid elongated body 157 into the coronary sinus adjacent to the posterior leaflet of the mitral valve, the annulus of the mitral valve is effectively manipulated so that it will assume an increased radius of curvature.
  • [0085]
    It has also been found that by inserting the straight, substantially rigid elongated body into the coronary sinus adjacent to the posterior leaflet of the mitral valve, the left ventricle may also be remodeled so as to help alleviate congestive heart failure.
  • [0086]
    It is significant to note that with the present invention, the distal and proximal ends of straight, substantially rigid elongated body 157 apply a posteriorly-directed force on the walls of coronary sinus 30 (e.g., as shown with arrows P in FIG. 7) while the intermediate portion of straight, substantially rigid elongated body 157 applies an anteriorly-directed force on the walls of coronary sinus 30 (e.g., as shown with arrows A in FIG. 7).
  • [0087]
    In some cases the proximal end 130 of delivery catheter 106 may be fixed to the patient's outer skin using standard patient care methods such as adhesive tape, pursestring sutures, skin staples, etc. In other cases proximal end 130 of delivery catheter 106 may include a sewing cuff whereby the delivery catheter may be secured to the patient's tissue by suturing. See, for example, FIG. 8, where a sewing cuff 166 is shown attached to the proximal end 130 of delivery catheter 106. If desired, an element 169 may be provided proximal to adjustable valve 133, whereby flexible push rod 109 may be made fast to delivery catheter 106. By way of example, element 169 may comprise a crimpable element to secure flexible push rod 109 to delivery catheter 106, which is in turn secured to the patient. If desired, the proximal end of the assembly may be embedded under the skin of the patient, e.g., in the case of a permanent implant.
  • [0088]
    As noted above, it can be helpful to anchor the distal end of delivery catheter 106 in position within the coronary sinus prior to pushing push rod 109 into the delivery catheter. Such an arrangement will keep the delivery catheter in place as the push rod makes the turn within the right atrium and enters the coronary sinus. In the absence of such anchoring, the push rod may drive the delivery catheter down the inferior vena cava 21. By securing the distal end of delivery catheter 106 to the walls of coronary sinus 30, the delivery catheter can be stabilized against diversion down the inferior vena cava 21 when the straight, substantially rigid elongate body 157 encounters initial resistance to making the turn into the coronary sinus.
  • [0089]
    The balloon 139 is one way of accomplishing such anchoring. However, it is also possible to utilize other types of securing mechanisms to anchor the distal end 127 of delivery catheter 106 in position within coronary sinus 30, e.g., spring clips, ribs, etc.
  • [0090]
    Alternatively, and looking next at FIG. 9, the distal end 151 of push rod 109 may itself be provided with a distal anchor, e.g., such as the distal anchor 172 shown in FIG. 9.
  • [0091]
    It is also possible to prevent diversion of delivery catheter 106 down inferior vena cava 21 without anchoring the distal end of delivery catheter 106 or flexible push rod 109 to the walls of the coronary sinus. More particularly, and looking now at FIG. 9A, there is shown a support catheter 173 which is formed out of a more rigid material than delivery catheter 106. Support catheter 173 is constructed so that its distal end 174 can be positioned in coronary ostium 27 and then its sidewall 174A can support delivery catheter 106 adjacent to inferior vena cava 21 when push rod 109 is passed down delivery catheter 106, whereby to prevent delivery catheter 106 from diverting down inferior vena cava 106. FIG. 9A also shows an introducer catheter 174B at the entrance to jugular vein 18.
  • [0092]
    As noted above, as push rod 109 is advanced to the region adjacent to the posterior annulus of the mitral valve, the straight, substantially rigid elongated body 157 will distort the natural configuration of the coronary sinus so that it will assume a substantially straight configuration. While this action induces the desired valve remodeling, it can also induce a significant stress on the walls of the coronary sinus, particularly at the distal and proximal ends of the straight, substantially rigid elongated body 157, where stress will be concentrated. To this end, the construction of the straight, substantially rigid elongated body 157 may be modified somewhat so as to better distribute this stress. More particularly, and looking next at FIG. 10, the distal and proximal ends of straight, substantially rigid elongated body 157 may include relatively flexible portions 175 to help better distribute the stress exerted on the walls of the coronary sinus. Additionally, and/or alternatively, any taper applied to the distal and proximal ends of straight, substantially rigid elongated body 157 may be elongated, e.g., such as shown at 178 in FIG. 11, so as to better distribute the stress imposed on the walls of the coronary sinus.
  • [0093]
    Looking next at FIG. 12, there is shown a system 181 which comprises another preferred embodiment of the present invention. More particularly, system 181 generally comprises the guidewire 103, a straight, substantially rigid elongated body 184 and a push cannula 187.
  • [0094]
    Guidewire 103 is as previously described.
  • [0095]
    Straight, substantially rigid elongated body 184, which may have a variety of different lengths, comprises a distal end 188 and a proximal end 190. A central lumen 193 extends between distal end 188 and proximal end 190. Central lumen 193 accommodates guidewire 103.
  • [0096]
    Push cannula 187 comprises a distal end 194 and a proximal end 196. A central lumen 199 extends between distal end 194 and proximal end 196. Central lumen 199 accommodates guidewire 103.
  • [0097]
    System 181 may be used as follows to reduce mitral regurgitation.
  • [0098]
    First, distal end 115 of guidewire 103 is passed down jugular vein 18 (or the left subclavian vein 15) of a patient, down superior vena cava 9, through right atrium 24 of the heart, and into coronary sinus 30. It will be appreciated that as flexible guidewire 103 is passed down coronary sinus 30, the guidewire will tend to assume the natural curved shape of the coronary sinus, due to the flexible nature of the guidewire. The guidewire's atraumatic spring tip 121 will help minimize damage to vascular structures as the guidewire is advanced into position.
  • [0099]
    Next, distal end 188 of straight, substantially rigid elongated body 184 is placed over proximal end 118 of guidewire 103 and passed a short distance down the guidewire. Then the distal end 194 of push cannula 187 is placed over proximal end 118 of guidewire 103, and then push cannula 187 is advanced down the guidewire. As push cannula 187 is advanced down the guidewire, its distal end 194 pushes the straight, substantially rigid elongated body 184 ahead of it. See FIG. 13.
  • [0100]
    As the straight, substantially rigid elongated body 184 is passed down the coronary sinus, it will force the coronary sinus to assume a straight configuration at the point where the straight, substantially rigid elongated body 184 currently resides. Push cannula 187 is pushed down guidewire as needed, until the straight, substantially rigid elongated body 184 is located adjacent to the posterior annulus of the mitral valve. As this occurs, the presence of the straight, substantially rigid elongated body 184 in the coronary sinus will cause coronary sinus to assume a substantially straight configuration at this point, so that the posterior annulus of the mitral valve is forced anteriorly. This will cause the posterior mitral valve leaflet to also move anteriorly so as to improve leaflet coaptation and thereby reduce (or completely eliminate) mitral valve regurgitation. Using standard visualization means (e.g. echocardiography or fluoroscopy), the exact position of the straight, substantially rigid elongated body may be adjusted so as to reduce (or completely eliminate) regurgitation in the mitral valve.
  • [0101]
    If desired, the push cannula 187 may be provided with a releasably attachable interface (e.g., a grasper) so that it may releasably secure the proximal end 190 of the straight, substantially rigid elongated body 184. Such a feature will permit the straight, substantially rigid elongated body to be pulled backward within the coronary sinus, either for positioning or removal purposes.
  • [0102]
    Alternatively, elongated body 184 or 157 may have any of a variety of non-straight shapes along its length. For example, the elongated body may be wavy, spiraled, or curved along all or a portion of its length. By way of example, elongated body 157 and/or 184 may have a curved configuration so as to invert the natural curvature of the coronary sinus, i.e., so that it is bowed towards the anterior annulus. Or the elongated body may have a compound shape along its length, e.g., it may have a sort of “w” shape, with the center of the “w” being directed towards the anterior annulus. Any of these or other alternate shapes may effect the anterior displacement of the posterior annulus that results in reduction of the mitral valve regurgitation.
  • [0103]
    In other alternative embodiments, the elongated body may be flexible along at least a portion of its length. Regional flexibility and regional stiffness may allow for straightening of select locations of the coronary sinus and corresponding locations of the posterior mitral annulus. This can cause regions of the mitral annulus to move anteriorly, thus causing regional improvements in leaflet coaptation. In addition, the elongated body may be formed by two end segments connected together by a filament: by anchoring the two end segments relative to the anatomy and pulling the filament taught, the naturally curved wall of the coronary sinus can be straightened, whereby to move the posterior mitral annulus anteriorly and thereby reduce mitral regurgitation.
  • [0104]
    In the preceding discussion, elongated body 157 (or 184) is generally described as being substantially straight and substantially rigid, with or without relatively flexible portions 175 (FIG. 10) and/or tapers 178 (FIG. 11). However, it should be appreciated that the terms “substantially straight”, “substantially rigid”, “relatively flexible”, and the like, are meant to be interpreted in the context of the anatomical tissue involved and should not be interpreted in an absolute sense.
  • [0105]
    Fundamentally, elongated body 157 (or 184) is constructed so that (1) its intermediate portion imparts an anteriorly-directed force on the walls of the coronary sinus (e.g., as shown by the arrows A in FIG. 7), and (2) its distal and proximal ends impart a posteriorly-directed force on the walls of the coronary sinus (e.g., as shown by the arrows P in FIG. 7). Conversely, a high center load is imparted to the intermediate portion of elongated body 157 (or 184) by the mitral annulus, and smaller end loads are directed to the distal and proximal ends of elongated body 157 (or 184) by the posterior portions of the coronary sinus.
  • [0106]
    Among other things, such an effect can be created by using an elongated body 157 (or 184) which is (1) straighter (but not necessarily perfectly straight) than the natural curvature of the portion of the coronary sinus adjacent to the posterior leaflet of the mitral annulus, and (2) more rigid (but not necessarily perfectly rigid) than the anatomical tissue which is to be displaced by the deployed elongated body 157 (or 184).
  • [0107]
    As noted above, in order to better distribute the loads on the proximal portions of the coronary sinus, the distal and proximal ends of elongated body 157 (or 184) may have relatively flexible portions 175 (FIG. 10) and/or tapers 178 (FIG. 11). Furthermore, the flexibility of these portions can vary along their length; thus, the elongated relatively flexible tapered portions 178 (FIG. 11) can become more flexible as they extend toward their outer ends.
  • [0108]
    Indeed, there is nothing in the present invention which requires that the intermediate portion of elongated body 157 (or 184) be absolutely rigid; in fact, it will function satisfactorily so long as it is substantially resistive to the high center load imposed by the mitral annulus. The design is further enhanced by having the distal and proximal ends of elongated body 157 (or 184) be somewhat less resistive to the smaller end loads directed by the posterior walls of the coronary sinus. Thus, a satisfactory design may be implemented with a device which has a rigidity gradient along its length, with a highest rigidity at or near the center and lower rigidity at or near its two ends (or, conversely, a flexibility gradient along its length, with a lowest flexibility at or near the center and a higher flexibility at or near its two ends). This may be accomplished by tapering the elongated body; and/or by varying its composition and/or material properties; and/or by other techniques which will be apparent to a person skilled in the art in view of the present disclosure. Or a satisfactory design may be implemented with a device which has some degree of flexibility along its entire length; and this flexibility may vary with length or it may be substantially constant along the entire length of the elongated body 157 (or 184).
  • [0109]
    Thus, as noted above, a satisfactory design may be implemented with an elongated body 157 (or 184) which is straighter (but not necessarily perfectly straight) than the natural curvature of the portion of the coronary sinus adjacent to the posterior leaflet of the mitral annulus, and (2) more rigid (but not necessarily perfectly rigid) than the anatomical tissue which is to be displaced by the deployed elongated body 157 (or 184).
  • [0110]
    In the system 100 described above, pushrod 109 (comprising the straight, substantially rigid elongated body 157) is delivered through delivery catheter 106. This construction can be advantageous inasmuch as the pushrod 109, and particularly its elongated body 157, can be shielded from direct contact with the host vascular tissue as the pushrod is advanced into its working position within the coronary sinus. As a result, the pushrod can be moved into working position with less trauma to the host vascular tissue.
  • [0111]
    The interior of delivery catheter 106 is typically filled with fluid (e.g., blood) when the delivery catheter is positioned within the vascular system of the patient. When pushrod 109 is advanced down the interior of delivery catheter 106, this fluid is generally forced out the distal end of the delivery catheter, with pushrod 109 (and particularly elongated body 157) acting as something of a piston.
  • [0112]
    Unfortunately, in some situations the distal end of delivery catheter 106 may become partially or completely closed off. This may occur for a variety of reasons, e.g., the distal end of the catheter could be positioned in a narrowed-down region of the blood vessel (FIG. 14), or the distal end of the catheter could be orthogonally engaging the side wall of a sharply-turning blood vessel, or the distal end of the catheter could be kinked over so as to close off the distal end of the catheter, or another, more-distal catheter-borne device could be blocking off the distal end of the catheter, etc.
  • [0113]
    In these and other situations, partial or complete closure of the distal end of the catheter can prevent fluid from escaping from the interior of the catheter. As a result, as pushrod 109 (and particularly elongated body 157) is advanced down the catheter, it meets the column of fluid and, inasmuch as the fluid is incompressible, encounters substantial resistance to advancement. This can render the device more difficult or even impossible for the operator to use. In addition, even where the operator can generate sufficient force to push the fluid out the distal end of the catheter, there is a danger that the fluid will be forced out with such pressure that it will damage the host tissue.
  • [0114]
    In view of the foregoing, it has been discovered that it can be advantageous to provide openings 200 (FIG. 15) in the side wall of delivery catheter 106. The openings 200 are preferably provided near to, but spaced from, the distal end 127 of the delivery catheter 106, although they may also be provided substantially anywhere along the length of the delivery catheter. The openings 200 permit fluid to escape from the interior of the delivery catheter 106 even when the distal end 127 of the delivery catheter is partially or completely blocked off, thus permitting easier passage of the pushrod 109 (and particularly elongated body 157) through a fluid filled catheter.
  • [0115]
    The aforementioned openings 200 may comprise holes 202, longitudinally-extending slits or slots, circumferentially-extending slits or slots 204, gills, and/or other aperture configurations so as to form the fenestrated catheter.
  • [0116]
    Referring to FIG. 16, it will be seen that the fenestrated catheter 106 may reside inside another catheter 173. The outer catheter 173 is dispsed around the fenestrated catheter 106 and spaced therefrom to define a passageway 176 between the outer wall of the catheter 106 and the inner wall of the catheter 173. The passageway may be annular or, if the inner catheter is not centered in the outer catheter, may be of any configuration defined by the two catheters, so long as the openings 200 are in communication with the passageway. Preferably, the passageway extends to a proximal end of the outer tube.
  • [0117]
    It should also be appreciated that the undesirable “piston effect” described above can be ameliorated to some extent through other constructions. For example, in system 100 shown in FIG. 3, delivery catheter 106 may be provided with one or more longitudinally-extending surface grooves 206 (FIGS. 17 and 18) so as to facilitate blood flow past the perimeter of delivery catheter 106.
  • [0118]
    Similarly, in system 181, shown in FIG. 12, elongated body 184 may be provided with one or more longitudinally-extending surface grooves 206 (FIGS. 19 and 20) so as to facilitate blood flow past the perimeter of elongated body 184.
  • [0119]
    It is to be understood that the present invention is by no means limited to the particular constructions herein disclosed and/or shown in the drawings, but also comprises any modifications or equivalents within the scope of the claims.

Claims (21)

    What is claimed is:
  1. 1. A method for reducing mitral regurgitation comprising:
    inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being configured to straighten the natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
  2. 2. A method for reducing mitral regurgitation comprising:
    inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being configured to move at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve anteriorly, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
  3. 3. A method for reducing mitral regurgitation comprising:
    inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being configured to reduce the degree of natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
  4. 4. A method for reducing mitral regurgitation comprising:
    inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being configured to increase the natural radius of curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
  5. 5. A method for reducing mitral regurgitation comprising:
    inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus having a distal end, a proximal end and an intermediate portion, the apparatus being configured so that when the apparatus is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends apply a posteriorly-directed force to the wall of the coronary sinus and the intermediate portion applies an anteriorly-directed force to the wall of the coronary sinus, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
  6. 6. A method for reducing mitral regurgitation comprising:
    inserting a substantially straight elongated body into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the substantially straight elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially straight elongated body is positioned in the coronary sinus, it causes at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mitral annulus and thereby improve leaflet coaptation.
  7. 7. A method for reducing mitral regurgitation comprising:
    inserting a substantially rigid elongated body into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the substantially rigid elongated body being configured relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially rigid elongated body is positioned in the coronary sinus, it causes at least a portion of the coronary sinus to assume a different configuration adjacent to the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
  8. 8. A method for reducing mitral regurgitation comprising:
    inserting a substantially straight, substantially rigid elongated body into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the substantially straight, substantially rigid elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially straight, substantially rigid elongated body is positioned in the coronary sinus, it causes at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mitral annulus and thereby improve leaflet coaptation.
  9. 9. An apparatus for reducing mitral regurgitation comprising:
    a body having a distal end, a proximal end and an intermediate portion, the body being configured so that when the body is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends apply a posteriorly-directed force to the wall of the coronary sinus, and the intermediate portion applies an anteriorly-directed force to the wall of the coronary sinus, whereby to move the posterior annulus of the mitral valve anteriorly and thereby improve leaflet coaptation.
  10. 10. An apparatus for reducing mitral regurgitation comprising:
    a substantially straight elongated body adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the substantially straight elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially straight elongated body is positioned in the coronary sinus, it causes at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mitral annulus, moving the posterior annulus anteriorly, and thereby improve leaflet coaptation.
  11. 11. An apparatus for reducing mitral regurgitation comprising:
    a substantially rigid elongated body adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the straight, substantially rigid elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially rigid elongated body is positioned in the coronary sinus, it causes at least a portion of the coronary sinus to assume a different configuration adjacent to the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
  12. 12. An apparatus for reducing mitral regurgitation comprising:
    a substantially straight, substantially rigid elongated body adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the straight, substantially rigid elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially straight, substantially rigid elongated body is positioned in the coronary sinus, it causes at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mitral annulus, moving the mitral annulus anteriorly, and thereby improve leaflet coaptation.
  13. 13. A catheter comprising:
    a flexible elongated delivery tube having a central lumen extending from a distal end of said tube to a proximal end of said tube, the flexibility of said tube being such as to permit closure of the distal end of said tube upon encounter with an impinging body structure, whereby to inhibit flow of fluid out the distal end of said tube; and
    orifice means defined by said tube in a side wall thereof, said orifice means being disposed proximate but spaced from the distal end of said tube, and configured to permit egress of fluid from said tube.
  14. 14. The catheter in accordance with claim 13 wherein said orifice means comprises at least a selected one of holes, longitudinally-extending slits, longitudinally-extending slots, circumferentially-extending slits, circumferentially-extending slots, gills, and apertures of selected configurations.
  15. 15. The catheter in accordance with claim 14 and further comprising:
    an outer flexible elongated tube disposed around said delivery tube and spaced therefrom to define a passageway between an outer wall of said delivery tube and an inner wall of said outer tube;
    wherein the passageway is in communication with said orifice means.
  16. 16. The catheter in accordance with claim 15 wherein the passageway extends to a proximal end of said outer tube.
  17. 17. The catheter in accordance with claim 15 wherein the passageway is annular in widthwise configuration.
  18. 18. A catheter comprising:
    a flexible elongated delivery tube having a central lumen extending from a distal end of said tube to a proximal end of said tube; and
    longitudinally extending surface grooves disposed in an outer surface of said tube to permit flow of fluid longitudinally of said tube.
  19. 19. The catheter in accordance with claim 18 wherein said tube is provided with a second lumen extending alongside the central lumen.
  20. 20. An apparatus for reducing mitral regurgitation, the apparatus comprising:
    a body having a distal end, a proximal end, and an intermediate portion, the body being configured such that when the body is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends apply a posteriorly-directed force to the wall of the coronary sinus, and the intermediate portion applies an anteriorly-directed force to the wall of the coronary sinus, whereby to move the posterior annulus of the mitral valve anteriorly and thereby improve leaflet coaption; and
    longitudinally extending grooves disposed in an outer surface of said body to permit flow of fluid longitudinally of said body.
  21. 21. The apparatus in accordance with claim 20 wherein said body is provided with a central lumen extending from the distal end of said body to the proximal end of said body.
US10607366 2002-02-05 2003-06-26 Method and apparatus for improving mitral valve function Abandoned US20040102839A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US39179002 true 2002-06-26 2002-06-26
US10446470 US7125420B2 (en) 2002-02-05 2003-05-27 Method and apparatus for improving mitral valve function
US10607366 US20040102839A1 (en) 2002-06-26 2003-06-26 Method and apparatus for improving mitral valve function

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10607366 US20040102839A1 (en) 2002-06-26 2003-06-26 Method and apparatus for improving mitral valve function

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10446470 Continuation-In-Part US7125420B2 (en) 2001-02-05 2003-05-27 Method and apparatus for improving mitral valve function

Publications (1)

Publication Number Publication Date
US20040102839A1 true true US20040102839A1 (en) 2004-05-27

Family

ID=30003211

Family Applications (3)

Application Number Title Priority Date Filing Date
US10446470 Active US7125420B2 (en) 2001-02-05 2003-05-27 Method and apparatus for improving mitral valve function
US10607366 Abandoned US20040102839A1 (en) 2002-02-05 2003-06-26 Method and apparatus for improving mitral valve function
US11582157 Abandoned US20070156235A1 (en) 2001-02-05 2006-10-17 Method and apparatus for improving mitral valve function

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10446470 Active US7125420B2 (en) 2001-02-05 2003-05-27 Method and apparatus for improving mitral valve function

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11582157 Abandoned US20070156235A1 (en) 2001-02-05 2006-10-17 Method and apparatus for improving mitral valve function

Country Status (2)

Country Link
US (3) US7125420B2 (en)
WO (1) WO2004002290A3 (en)

Cited By (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020029080A1 (en) * 1997-12-17 2002-03-07 Myocor, Inc. Valve to myocardium tension members device and method
US20030171776A1 (en) * 2002-03-06 2003-09-11 Cardiac Dimensions, Inc. Transvenous staples, assembly and method for mitral valve repair
US20030236569A1 (en) * 2002-01-30 2003-12-25 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20040010305A1 (en) * 2001-12-05 2004-01-15 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20040039443A1 (en) * 1999-06-30 2004-02-26 Solem Jan Otto Method and device for treatment of mitral insufficiency
US20040059411A1 (en) * 2000-10-26 2004-03-25 Strecker Ernst Peter Implantable valve system
US20040127848A1 (en) * 2002-12-30 2004-07-01 Toby Freyman Valve treatment catheter and methods
US20040133220A1 (en) * 2000-01-31 2004-07-08 Randall Lashinski Adjustable transluminal annuloplasty system
US20040153147A1 (en) * 2003-02-03 2004-08-05 Cardiac Dimensions, Inc. Mitral valve device using conditioned shape memory alloy
US20040158321A1 (en) * 2003-02-12 2004-08-12 Cardiac Dimensions, Inc. Method of implanting a mitral valve therapy device
US20040186566A1 (en) * 2003-03-18 2004-09-23 Hindrichs Paul J. Body tissue remodeling methods and apparatus
US20040254600A1 (en) * 2003-02-26 2004-12-16 David Zarbatany Methods and devices for endovascular mitral valve correction from the left coronary sinus
US20050010240A1 (en) * 2003-06-05 2005-01-13 Cardiac Dimensions Inc., A Washington Corporation Device and method for modifying the shape of a body organ
US20050021121A1 (en) * 2001-11-01 2005-01-27 Cardiac Dimensions, Inc., A Delaware Corporation Adjustable height focal tissue deflector
US20050027353A1 (en) * 2001-05-14 2005-02-03 Alferness Clifton A. Mitral valve therapy device, system and method
US20050085903A1 (en) * 2003-10-17 2005-04-21 Jan Lau Heart valve leaflet locator
US20050096740A1 (en) * 2001-01-30 2005-05-05 Edwards Lifesciences Ag Transluminal mitral annuloplasty
US20050096666A1 (en) * 2002-12-05 2005-05-05 Gordon Lucas S. Percutaneous mitral valve annuloplasty delivery system
US20050119673A1 (en) * 2002-12-05 2005-06-02 Gordon Lucas S. Percutaneous mitral valve annuloplasty device delivery method
US20050137451A1 (en) * 2003-12-19 2005-06-23 Cardiac Dimensions, Inc. A Washington Corporation Tissue shaping device with integral connector and crimp
US20050137449A1 (en) * 2003-12-19 2005-06-23 Cardiac Dimensions, Inc. Tissue shaping device with self-expanding anchors
US20050137450A1 (en) * 2003-12-19 2005-06-23 Cardiac Dimensions, Inc., A Washington Corporation Tapered connector for tissue shaping device
US20050137685A1 (en) * 2003-12-19 2005-06-23 Cardiac Dimensions, Inc., A Washington Corporation Reduced length tissue shaping device
US20050149179A1 (en) * 2002-05-08 2005-07-07 Mathis Mark L. Body lumen device anchor, device and assembly
US20050171601A1 (en) * 2000-10-05 2005-08-04 Cosgrove Delos M. Minimally-invasive annuloplasty repair segment delivery system
US20050209690A1 (en) * 2002-01-30 2005-09-22 Mathis Mark L Body lumen shaping device with cardiac leads
US20050216077A1 (en) * 2002-01-30 2005-09-29 Mathis Mark L Fixed length anchor and pull mitral valve device and method
US20050222678A1 (en) * 2004-04-05 2005-10-06 Lashinski Randall T Remotely adjustable coronary sinus implant
US6964683B2 (en) 2002-12-26 2005-11-15 Cardiac Dimensions, Inc. System and method to effect the mitral valve annulus of a heart
US20060116758A1 (en) * 2003-06-05 2006-06-01 Gary Swinford Device, System and Method to Affect the Mitral Valve Annulus of a Heart
US20060129051A1 (en) * 2004-12-09 2006-06-15 Rowe Stanton J Diagnostic kit to assist with heart valve annulus adjustment
US20060142854A1 (en) * 2001-12-05 2006-06-29 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20060161169A1 (en) * 2003-05-02 2006-07-20 Cardiac Dimensions, Inc., A Delaware Corporation Device and method for modifying the shape of a body organ
US20060167544A1 (en) * 2005-01-20 2006-07-27 Cardiac Dimensions, Inc. Tissue Shaping Device
US20060241747A1 (en) * 2005-04-21 2006-10-26 Emanuel Shaoulian Dynamically adjustable implants and methods for reshaping tissue
US20060276891A1 (en) * 2003-12-19 2006-12-07 Gregory Nieminen Mitral Valve Annuloplasty Device with Twisted Anchor
US20070239270A1 (en) * 2006-04-11 2007-10-11 Mathis Mark L Mitral Valve Annuloplasty Device with Vena Cava Anchor
US20070282375A1 (en) * 2006-05-03 2007-12-06 St. Jude Medical, Inc. Soft body tissue remodeling methods and apparatus
US20080015407A1 (en) * 2003-05-02 2008-01-17 Mathis Mark L Device and Method for Modifying the Shape of a Body Organ
US20080087608A1 (en) * 2006-10-10 2008-04-17 Multiphase Systems Integration Compact multiphase inline bulk water separation method and system for hydrocarbon production
US7666224B2 (en) 2002-11-12 2010-02-23 Edwards Lifesciences Llc Devices and methods for heart valve treatment
US7670368B2 (en) 2005-02-07 2010-03-02 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7678145B2 (en) 2002-01-09 2010-03-16 Edwards Lifesciences Llc Devices and methods for heart valve treatment
US7682385B2 (en) 2002-04-03 2010-03-23 Boston Scientific Corporation Artificial valve
US7695425B2 (en) 1997-01-02 2010-04-13 Edwards Lifesciences Llc Heart wall tension reduction apparatus and method
US7695512B2 (en) 2000-01-31 2010-04-13 Edwards Lifesciences Ag Remotely activated mitral annuloplasty system and methods
US7722666B2 (en) 2005-04-15 2010-05-25 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US7722523B2 (en) 1998-07-29 2010-05-25 Edwards Lifesciences Llc Transventricular implant tools and devices
US7766812B2 (en) 2000-10-06 2010-08-03 Edwards Lifesciences Llc Methods and devices for improving mitral valve function
US7780722B2 (en) 2005-02-07 2010-08-24 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7799038B2 (en) 2006-01-20 2010-09-21 Boston Scientific Scimed, Inc. Translumenal apparatus, system, and method
US7854761B2 (en) 2003-12-19 2010-12-21 Boston Scientific Scimed, Inc. Methods for venous valve replacement with a catheter
US7854755B2 (en) 2005-02-01 2010-12-21 Boston Scientific Scimed, Inc. Vascular catheter, system, and method
US7867274B2 (en) 2005-02-23 2011-01-11 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US7878966B2 (en) 2005-02-04 2011-02-01 Boston Scientific Scimed, Inc. Ventricular assist and support device
US7883539B2 (en) 1997-01-02 2011-02-08 Edwards Lifesciences Llc Heart wall tension reduction apparatus and method
US7892276B2 (en) 2007-12-21 2011-02-22 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US7951189B2 (en) 2005-09-21 2011-05-31 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US7967853B2 (en) 2007-02-05 2011-06-28 Boston Scientific Scimed, Inc. Percutaneous valve, system and method
US8002824B2 (en) 2004-09-02 2011-08-23 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
US8006594B2 (en) * 2008-08-11 2011-08-30 Cardiac Dimensions, Inc. Catheter cutting tool
US8012198B2 (en) 2005-06-10 2011-09-06 Boston Scientific Scimed, Inc. Venous valve, system, and method
US8128681B2 (en) 2003-12-19 2012-03-06 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US8133270B2 (en) 2007-01-08 2012-03-13 California Institute Of Technology In-situ formation of a valve
WO2013088327A1 (en) 2011-12-12 2013-06-20 David Alon Heart valve repair device
US8506624B2 (en) 2002-01-09 2013-08-13 Edwards Lifesciences, Llc Devices and methods for heart valve treatment
US8828079B2 (en) 2007-07-26 2014-09-09 Boston Scientific Scimed, Inc. Circulatory valve, system and method
WO2014195786A2 (en) 2013-06-06 2014-12-11 David Alon Heart valve repair and replacement
US8992605B2 (en) 2004-09-14 2015-03-31 Edwards Lifesciences Ag Device and method for reducing mitral valve regurgitation
US9492277B2 (en) 2005-08-30 2016-11-15 Mayo Foundation For Medical Education And Research Soft body tissue remodeling methods and apparatus
US9622859B2 (en) 2005-02-01 2017-04-18 Boston Scientific Scimed, Inc. Filter system and method
US9668859B2 (en) 2011-08-05 2017-06-06 California Institute Of Technology Percutaneous heart valve delivery systems
US9744037B2 (en) 2013-03-15 2017-08-29 California Institute Of Technology Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69841237D1 (en) * 1997-06-27 2009-11-26 Univ Columbia Apparatus for repairing circuit flaps
FR2768324B1 (en) 1997-09-12 1999-12-10 Jacques Seguin A surgical instrument for percutaneously, fixing one to the other two zones of soft tissue, usually spaced apart
US8216256B2 (en) 1999-04-09 2012-07-10 Evalve, Inc. Detachment mechanism for implantable fixation devices
US7563267B2 (en) 1999-04-09 2009-07-21 Evalve, Inc. Fixation device and methods for engaging tissue
US7811296B2 (en) 1999-04-09 2010-10-12 Evalve, Inc. Fixation devices for variation in engagement of tissue
US20040044350A1 (en) * 1999-04-09 2004-03-04 Evalve, Inc. Steerable access sheath and methods of use
US20070038293A1 (en) * 1999-04-09 2007-02-15 St Goar Frederick G Device and methods for endoscopic annuloplasty
WO2000060995A9 (en) 1999-04-09 2002-06-13 Evalve Inc Methods and apparatus for cardiac valve repair
US6752813B2 (en) 1999-04-09 2004-06-22 Evalve, Inc. Methods and devices for capturing and fixing leaflets in valve repair
US6210432B1 (en) * 1999-06-29 2001-04-03 Jan Otto Solem Device and method for treatment of mitral insufficiency
EP1113497A3 (en) * 1999-12-29 2006-01-25 Texas Instruments Incorporated Semiconductor package with conductor impedance selected during assembly
US7125420B2 (en) * 2002-02-05 2006-10-24 Viacor, Inc. Method and apparatus for improving mitral valve function
US7186264B2 (en) * 2001-03-29 2007-03-06 Viacor, Inc. Method and apparatus for improving mitral valve function
US6676702B2 (en) * 2001-05-14 2004-01-13 Cardiac Dimensions, Inc. Mitral valve therapy assembly and method
US6575971B2 (en) * 2001-11-15 2003-06-10 Quantum Cor, Inc. Cardiac valve leaflet stapler device and methods thereof
US7192443B2 (en) * 2002-01-11 2007-03-20 Edwards Lifesciences Ag Delayed memory device
US6960229B2 (en) * 2002-01-30 2005-11-01 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US6797001B2 (en) * 2002-03-11 2004-09-28 Cardiac Dimensions, Inc. Device, assembly and method for mitral valve repair
US7007698B2 (en) * 2002-04-03 2006-03-07 Boston Scientific Corporation Body lumen closure
CA2533556A1 (en) * 2003-07-23 2005-02-03 Viacor, Inc. Method and apparatus for improving mitral valve function
US7056286B2 (en) 2003-11-12 2006-06-06 Adrian Ravenscroft Medical device anchor and delivery system
US20050177228A1 (en) * 2003-12-16 2005-08-11 Solem Jan O. Device for changing the shape of the mitral annulus
EP1750592B1 (en) 2004-05-14 2016-12-28 Evalve, Inc. Locking mechanisms for fixation devices
JP5162238B2 (en) * 2004-07-05 2013-03-13 ネスルンド,インゲマールNaeslund, Ingemar The positioning marker in living tissue
US7635329B2 (en) * 2004-09-27 2009-12-22 Evalve, Inc. Methods and devices for tissue grasping and assessment
US8052592B2 (en) 2005-09-27 2011-11-08 Evalve, Inc. Methods and devices for tissue grasping and assessment
CA2588653A1 (en) * 2004-11-24 2006-06-01 Viacor, Inc. Method and apparatus for improving mitral valve function
WO2011034628A1 (en) 2005-02-07 2011-03-24 Evalve, Inc. Methods, systems and devices for cardiac valve repair
CA2597066C (en) * 2005-02-07 2014-04-15 Evalve, Inc. Methods, systems and devices for cardiac valve repair
US7500989B2 (en) * 2005-06-03 2009-03-10 Edwards Lifesciences Corp. Devices and methods for percutaneous repair of the mitral valve via the coronary sinus
WO2007021893A1 (en) * 2005-08-12 2007-02-22 Edwards Lifesciences Corporation Medical implant with reinforcement mechanism
US20080221673A1 (en) * 2005-08-12 2008-09-11 Donald Bobo Medical implant with reinforcement mechanism
WO2007035726A3 (en) * 2005-09-19 2009-05-07 Mayo Foundation Implantable closure apparatus and methods
US20070073391A1 (en) * 2005-09-28 2007-03-29 Henry Bourang System and method for delivering a mitral valve repair device
US20070173926A1 (en) * 2005-12-09 2007-07-26 Bobo Donald E Jr Anchoring system for medical implant
US7637946B2 (en) 2006-02-09 2009-12-29 Edwards Lifesciences Corporation Coiled implant for mitral valve repair
US20080065205A1 (en) * 2006-09-11 2008-03-13 Duy Nguyen Retrievable implant and method for treatment of mitral regurgitation
US20080255447A1 (en) * 2007-04-16 2008-10-16 Henry Bourang Diagnostic catheter
US8100820B2 (en) 2007-08-22 2012-01-24 Edwards Lifesciences Corporation Implantable device for treatment of ventricular dilation
US20090222081A1 (en) * 2008-01-24 2009-09-03 Coherex Medical, Inc. Methods and apparatus for reducing valve prolapse
US20100030330A1 (en) * 2008-08-01 2010-02-04 Edwards Lifesciences Corporation Device and method for mitral valve repair
EP3042615A1 (en) 2009-09-15 2016-07-13 Evalve, Inc. Methods, systems and devices for cardiac valve repair
US9649211B2 (en) 2009-11-04 2017-05-16 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
CN103491900B (en) 2010-12-23 2017-03-01 托尔福公司 For mitral valve repair and replacement of system
CN107647939A (en) 2011-06-21 2018-02-02 托尔福公司 Prosthetic heart valve devices and related systems
US9039757B2 (en) 2011-10-19 2015-05-26 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
EP2750631A1 (en) 2011-10-19 2014-07-09 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9655722B2 (en) 2011-10-19 2017-05-23 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9763780B2 (en) 2011-10-19 2017-09-19 Twelve, Inc. Devices, systems and methods for heart valve replacement
US20160324636A1 (en) * 2012-02-13 2016-11-10 Mitraspan, Inc. Method and apparatus for repairing a mitral valve
US9579198B2 (en) 2012-03-01 2017-02-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods

Citations (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1786264A (en) * 1927-10-14 1930-12-23 Sylvanus A Reed Energy-transmission means
US4266999A (en) * 1979-07-30 1981-05-12 Calspan Corporation Catheter for long-term emplacement
US4413989A (en) * 1980-09-08 1983-11-08 Angiomedics Corporation Expandable occlusion apparatus
US4535757A (en) * 1982-03-12 1985-08-20 Webster Wilton W Jr Autoinflatable catheter
US4669473A (en) * 1985-09-06 1987-06-02 Acufex Microsurgical, Inc. Surgical fastener
US4917698A (en) * 1988-12-22 1990-04-17 Baxter International Inc. Multi-segmented annuloplasty ring prosthesis
US4944745A (en) * 1988-02-29 1990-07-31 Scimed Life Systems, Inc. Perfusion balloon catheter
US5061277A (en) * 1986-08-06 1991-10-29 Baxter International Inc. Flexible cardiac valvular support prosthesis
US5092889A (en) * 1989-04-14 1992-03-03 Campbell Robert M Jr Expandable vertical prosthetic rib
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US5195972A (en) * 1988-10-28 1993-03-23 Kanji Inoue Balloon catheter assembly
US5269809A (en) * 1990-07-02 1993-12-14 American Cyanamid Company Locking mechanism for use with a slotted suture anchor
US5332402A (en) * 1992-05-12 1994-07-26 Teitelbaum George P Percutaneously-inserted cardiac valve
US5345937A (en) * 1991-02-15 1994-09-13 Raychem Corporation Steerable cannula
US5383892A (en) * 1991-11-08 1995-01-24 Meadox France Stent for transluminal implantation
US5389091A (en) * 1991-03-07 1995-02-14 C. R. Bard, Inc. Site-selective durability-enhanced catheter and methods of manufacturing and using same
US5443481A (en) * 1992-07-27 1995-08-22 Lee; Benjamin I. Methods and device for percutaneous sealing of arterial puncture sites
US5462530A (en) * 1992-04-09 1995-10-31 Jang; G. David Intravascular catheter with bailout feature
US5476506A (en) * 1994-02-08 1995-12-19 Ethicon, Inc. Bi-directional crimped graft
US5509900A (en) * 1992-03-02 1996-04-23 Kirkman; Thomas R. Apparatus and method for retaining a catheter in a blood vessel in a fixed position
US5514092A (en) * 1994-08-08 1996-05-07 Schneider (Usa) Inc. Drug delivery and dilatation-drug delivery catheters in a rapid exchange configuration
US5527292A (en) * 1990-10-29 1996-06-18 Scimed Life Systems, Inc. Intravascular device for coronary heart treatment
US5545209A (en) * 1993-09-30 1996-08-13 Texas Petrodet, Inc. Controlled deployment of a medical device
US5562620A (en) * 1994-04-01 1996-10-08 Localmed, Inc. Perfusion shunt device having non-distensible pouch for receiving angioplasty balloon
US5569198A (en) * 1995-01-23 1996-10-29 Cortrak Medical Inc. Microporous catheter
US5569201A (en) * 1989-04-13 1996-10-29 Scimed Life Systems, Inc. Balloon catheter with distal seal
US5575799A (en) * 1995-03-30 1996-11-19 United States Surgical Corporation Articulating surgical apparatus
US5681345A (en) * 1995-03-01 1997-10-28 Scimed Life Systems, Inc. Sleeve carrying stent
US5720726A (en) * 1992-12-30 1998-02-24 Medtronic, Inc. Balloon catheter having retention enhancements on the balloon
US5733665A (en) * 1991-11-15 1998-03-31 Fujicopian Co., Ltd. Multi-usable thermal transfer ink sheet
US5743875A (en) * 1991-05-15 1998-04-28 Advanced Cardiovascular Systems, Inc. Catheter shaft with an oblong transverse cross-section
US5755778A (en) * 1996-10-16 1998-05-26 Nitinol Medical Technologies, Inc. Anastomosis device
US5755781A (en) * 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents
US5800495A (en) * 1997-03-27 1998-09-01 Sulzer Intermedics Inc. Endocardial lead assembly
US5800526A (en) * 1995-03-17 1998-09-01 Endotex Interventional Systems, Inc. Multi-anchor stent
US5855565A (en) * 1997-02-21 1999-01-05 Bar-Cohen; Yaniv Cardiovascular mechanically expanding catheter
US5911732A (en) * 1997-03-10 1999-06-15 Johnson & Johnson Interventional Systems, Co. Articulated expandable intraluminal stent
US5957949A (en) * 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US5968009A (en) * 1997-01-29 1999-10-19 Baxter International Inc. Double lumen tubing design for catheter
US5980570A (en) * 1998-03-27 1999-11-09 Sulzer Carbomedics Inc. System and method for implanting an expandable medical device into a body
US5984917A (en) * 1995-06-07 1999-11-16 Ep Technologies, Inc. Device and method for remote insertion of a closed loop
US6033436A (en) * 1998-02-17 2000-03-07 Md3, Inc. Expandable stent
US6051020A (en) * 1994-02-09 2000-04-18 Boston Scientific Technology, Inc. Bifurcated endoluminal prosthesis
US6086599A (en) * 1999-02-08 2000-07-11 The Regents Of The University Of California Micro devices using shape memory polymer patches for mated connections
US6090136A (en) * 1996-07-29 2000-07-18 Radiance Medical Systems, Inc. Self expandable tubular support
US6102945A (en) * 1998-10-16 2000-08-15 Sulzer Carbomedics, Inc. Separable annuloplasty ring
US6119037A (en) * 1995-06-06 2000-09-12 Board Of Regents, The University Of Texas System Electrode system in iontophoretic treatment devices
US6149696A (en) * 1997-11-06 2000-11-21 Komag, Inc. Colloidal silica slurry for NiP plated disk polishing
US6162245A (en) * 1997-05-07 2000-12-19 Iowa-India Investments Company Limited Stent valve and stent graft
US6165194A (en) * 1998-07-24 2000-12-26 Micrus Corporation Intravascular flow modifier and reinforcement device
US6187040B1 (en) * 1999-05-03 2001-02-13 John T. M. Wright Mitral and tricuspid annuloplasty rings
US6210432B1 (en) * 1999-06-29 2001-04-03 Jan Otto Solem Device and method for treatment of mitral insufficiency
US6241746B1 (en) * 1998-06-29 2001-06-05 Cordis Corporation Vascular filter convertible to a stent and method
US6258117B1 (en) * 1999-04-15 2001-07-10 Mayo Foundation For Medical Education And Research Multi-section stent
US6277107B1 (en) * 1993-08-13 2001-08-21 Daig Corporation Guiding introducer for introducing medical devices into the coronary sinus and process for using same
US6287336B1 (en) * 1995-10-16 2001-09-11 Medtronic, Inc. Variable flexibility stent
US6328765B1 (en) * 1998-12-03 2001-12-11 Gore Enterprise Holdings, Inc. Methods and articles for regenerating living tissue
US6332896B1 (en) * 1994-07-14 2001-12-25 Ortho Development Corporation Orthopaedic implant with proximal collar
US6402781B1 (en) * 2000-01-31 2002-06-11 Mitralife Percutaneous mitral annuloplasty and cardiac reinforcement
US20020087173A1 (en) * 2000-12-28 2002-07-04 Alferness Clifton A. Mitral valve constricting device, system and method
US20020099431A1 (en) * 2001-01-22 2002-07-25 Armstrong Joseph R. Deployment system for intraluminal devices
US6524301B1 (en) * 2000-12-21 2003-02-25 Advanced Cardiovascular Systems, Inc. Guidewire with an intermediate variable stiffness section
US20030078654A1 (en) * 2001-08-14 2003-04-24 Taylor Daniel C. Method and apparatus for improving mitral valve function
US6585716B2 (en) * 2000-04-05 2003-07-01 Biocardia, Inc. Method of treating the heart
US6602288B1 (en) * 2000-10-05 2003-08-05 Edwards Lifesciences Corporation Minimally-invasive annuloplasty repair segment delivery template, system and method of use
US6648874B2 (en) * 2000-02-28 2003-11-18 Scimed Life Systems, Inc. Guide catheter with lubricious inner liner
US6656221B2 (en) * 2001-02-05 2003-12-02 Viacor, Inc. Method and apparatus for improving mitral valve function
US20050222678A1 (en) * 2004-04-05 2005-10-06 Lashinski Randall T Remotely adjustable coronary sinus implant
US7052487B2 (en) * 2001-10-26 2006-05-30 Cohn William E Method and apparatus for reducing mitral regurgitation

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307723A (en) * 1978-04-07 1981-12-29 Medical Engineering Corporation Externally grooved ureteral stent
US4485816A (en) * 1981-06-25 1984-12-04 Alchemia Shape-memory surgical staple apparatus and method for use in surgical suturing
DE3204532C2 (en) * 1982-02-10 1983-12-08 B. Braun Melsungen Ag, 3508 Melsungen, De
US4733665C2 (en) * 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4893623A (en) * 1986-12-09 1990-01-16 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US4841960A (en) * 1987-02-10 1989-06-27 Garner Eric T Method and apparatus for interosseous bone fixation
US5318529A (en) * 1989-09-06 1994-06-07 Boston Scientific Corporation Angioplasty balloon catheter and adaptor
CA2026604A1 (en) * 1989-10-02 1991-04-03 Rodney G. Wolff Articulated stent
US6821287B1 (en) * 1991-05-24 2004-11-23 Advanced Cardiovascular Systems, Inc. Multi-mode vascular catheter system
US5334185A (en) * 1991-06-28 1994-08-02 Giesy Consultants, Inc. End-to-end instrument placement apparatus
US5584803A (en) * 1991-07-16 1996-12-17 Heartport, Inc. System for cardiac procedures
US5236440A (en) * 1992-04-14 1993-08-17 American Cyanamid Company Surgical fastener
US5484451A (en) * 1992-05-08 1996-01-16 Ethicon, Inc. Endoscopic surgical instrument and staples for applying purse string sutures
US5797960A (en) * 1993-02-22 1998-08-25 Stevens; John H. Method and apparatus for thoracoscopic intracardiac procedures
US5450860A (en) * 1993-08-31 1995-09-19 W. L. Gore & Associates, Inc. Device for tissue repair and method for employing same
US5593424A (en) * 1994-08-10 1997-01-14 Segmed, Inc. Apparatus and method for reducing and stabilizing the circumference of a vascular structure
CA2179083A1 (en) 1995-08-01 1997-02-02 Michael S. Williams Composite metal and polymer locking stents for drug delivery
US5797951A (en) * 1995-08-09 1998-08-25 Mueller; Edward Gene Expandable support member
US5637091A (en) * 1995-08-31 1997-06-10 Hakky; Said I. Collapsible catheter
US5716370A (en) * 1996-02-23 1998-02-10 Williamson, Iv; Warren Means for replacing a heart valve in a minimally invasive manner
JPH09322936A (en) 1996-06-06 1997-12-16 A S A Sangyo Kk Catheter for peritoneal dialysis and dialytic liquid container
US5911752A (en) * 1996-09-13 1999-06-15 Intratherapeutics, Inc. Method for collapsing a stent
US5947999A (en) * 1996-12-03 1999-09-07 Groiso; Jorge A. Surgical clip and method
US6206911B1 (en) * 1996-12-19 2001-03-27 Simcha Milo Stent combination
US5971983A (en) * 1997-05-09 1999-10-26 The Regents Of The University Of California Tissue ablation device and method of use
US6083259A (en) * 1998-11-16 2000-07-04 Frantzen; John J. Axially non-contracting flexible radially expandable stent
US7192442B2 (en) 1999-06-30 2007-03-20 Edwards Lifesciences Ag Method and device for treatment of mitral insufficiency
CA2433881C (en) 2001-01-30 2009-08-18 Randall T. Lashinski Medical system and method for remodeling an extravascular tissue structure
US6810882B2 (en) 2001-01-30 2004-11-02 Ev3 Santa Rosa, Inc. Transluminal mitral annuloplasty
US6989028B2 (en) 2000-01-31 2006-01-24 Edwards Lifesciences Ag Medical system and method for remodeling an extravascular tissue structure
US6569198B1 (en) 2000-03-31 2003-05-27 Richard A. Wilson Mitral or tricuspid valve annuloplasty prosthetic device
US6638268B2 (en) 2000-04-07 2003-10-28 Imran K. Niazi Catheter to cannulate the coronary sinus
US6419696B1 (en) 2000-07-06 2002-07-16 Paul A. Spence Annuloplasty devices and related heart valve repair methods
US7186264B2 (en) * 2001-03-29 2007-03-06 Viacor, Inc. Method and apparatus for improving mitral valve function
US7125420B2 (en) * 2002-02-05 2006-10-24 Viacor, Inc. Method and apparatus for improving mitral valve function
US6676702B2 (en) 2001-05-14 2004-01-13 Cardiac Dimensions, Inc. Mitral valve therapy assembly and method
US6800090B2 (en) 2001-05-14 2004-10-05 Cardiac Dimensions, Inc. Mitral valve therapy device, system and method
US6949122B2 (en) 2001-11-01 2005-09-27 Cardiac Dimensions, Inc. Focused compression mitral valve device and method
US6805710B2 (en) 2001-11-13 2004-10-19 Edwards Lifesciences Corporation Mitral valve annuloplasty ring for molding left ventricle geometry
US6908478B2 (en) 2001-12-05 2005-06-21 Cardiac Dimensions, Inc. Anchor and pull mitral valve device and method
US6797001B2 (en) * 2002-03-11 2004-09-28 Cardiac Dimensions, Inc. Device, assembly and method for mitral valve repair
US7485143B2 (en) * 2002-11-15 2009-02-03 Abbott Cardiovascular Systems Inc. Apparatuses and methods for heart valve repair
EP1592344A4 (en) * 2003-01-31 2006-08-16 Univ Leland Stanford Junior Detection of apex motion for monitoring cardiac dysfunction
CA2533556A1 (en) * 2003-07-23 2005-02-03 Viacor, Inc. Method and apparatus for improving mitral valve function

Patent Citations (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1786264A (en) * 1927-10-14 1930-12-23 Sylvanus A Reed Energy-transmission means
US4266999A (en) * 1979-07-30 1981-05-12 Calspan Corporation Catheter for long-term emplacement
US4413989A (en) * 1980-09-08 1983-11-08 Angiomedics Corporation Expandable occlusion apparatus
US4535757A (en) * 1982-03-12 1985-08-20 Webster Wilton W Jr Autoinflatable catheter
US4669473A (en) * 1985-09-06 1987-06-02 Acufex Microsurgical, Inc. Surgical fastener
US5061277B1 (en) * 1986-08-06 2000-02-29 Baxter Travenol Lab Flexible cardiac valvular support prosthesis
US5061277A (en) * 1986-08-06 1991-10-29 Baxter International Inc. Flexible cardiac valvular support prosthesis
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US4944745A (en) * 1988-02-29 1990-07-31 Scimed Life Systems, Inc. Perfusion balloon catheter
US5195972A (en) * 1988-10-28 1993-03-23 Kanji Inoue Balloon catheter assembly
US4917698A (en) * 1988-12-22 1990-04-17 Baxter International Inc. Multi-segmented annuloplasty ring prosthesis
US5569201A (en) * 1989-04-13 1996-10-29 Scimed Life Systems, Inc. Balloon catheter with distal seal
US5092889A (en) * 1989-04-14 1992-03-03 Campbell Robert M Jr Expandable vertical prosthetic rib
US5269809A (en) * 1990-07-02 1993-12-14 American Cyanamid Company Locking mechanism for use with a slotted suture anchor
US5527292A (en) * 1990-10-29 1996-06-18 Scimed Life Systems, Inc. Intravascular device for coronary heart treatment
US5345937A (en) * 1991-02-15 1994-09-13 Raychem Corporation Steerable cannula
US5389091A (en) * 1991-03-07 1995-02-14 C. R. Bard, Inc. Site-selective durability-enhanced catheter and methods of manufacturing and using same
US5743875A (en) * 1991-05-15 1998-04-28 Advanced Cardiovascular Systems, Inc. Catheter shaft with an oblong transverse cross-section
US5383892A (en) * 1991-11-08 1995-01-24 Meadox France Stent for transluminal implantation
US5733665A (en) * 1991-11-15 1998-03-31 Fujicopian Co., Ltd. Multi-usable thermal transfer ink sheet
US5509900A (en) * 1992-03-02 1996-04-23 Kirkman; Thomas R. Apparatus and method for retaining a catheter in a blood vessel in a fixed position
US6071263A (en) * 1992-03-02 2000-06-06 Kirkman; Thomas R. Apparatus and method for retaining a catheter in a blood vessel in a fixed position
US5462530A (en) * 1992-04-09 1995-10-31 Jang; G. David Intravascular catheter with bailout feature
US5332402A (en) * 1992-05-12 1994-07-26 Teitelbaum George P Percutaneously-inserted cardiac valve
US5443481A (en) * 1992-07-27 1995-08-22 Lee; Benjamin I. Methods and device for percutaneous sealing of arterial puncture sites
US5720726A (en) * 1992-12-30 1998-02-24 Medtronic, Inc. Balloon catheter having retention enhancements on the balloon
US6277107B1 (en) * 1993-08-13 2001-08-21 Daig Corporation Guiding introducer for introducing medical devices into the coronary sinus and process for using same
US5545209A (en) * 1993-09-30 1996-08-13 Texas Petrodet, Inc. Controlled deployment of a medical device
US5476506A (en) * 1994-02-08 1995-12-19 Ethicon, Inc. Bi-directional crimped graft
US6051020A (en) * 1994-02-09 2000-04-18 Boston Scientific Technology, Inc. Bifurcated endoluminal prosthesis
US5562620A (en) * 1994-04-01 1996-10-08 Localmed, Inc. Perfusion shunt device having non-distensible pouch for receiving angioplasty balloon
US6332896B1 (en) * 1994-07-14 2001-12-25 Ortho Development Corporation Orthopaedic implant with proximal collar
US5514092A (en) * 1994-08-08 1996-05-07 Schneider (Usa) Inc. Drug delivery and dilatation-drug delivery catheters in a rapid exchange configuration
US5569198A (en) * 1995-01-23 1996-10-29 Cortrak Medical Inc. Microporous catheter
US5681345A (en) * 1995-03-01 1997-10-28 Scimed Life Systems, Inc. Sleeve carrying stent
US5800526A (en) * 1995-03-17 1998-09-01 Endotex Interventional Systems, Inc. Multi-anchor stent
US5575799A (en) * 1995-03-30 1996-11-19 United States Surgical Corporation Articulating surgical apparatus
US6119037A (en) * 1995-06-06 2000-09-12 Board Of Regents, The University Of Texas System Electrode system in iontophoretic treatment devices
US5984917A (en) * 1995-06-07 1999-11-16 Ep Technologies, Inc. Device and method for remote insertion of a closed loop
US6287336B1 (en) * 1995-10-16 2001-09-11 Medtronic, Inc. Variable flexibility stent
US6090136A (en) * 1996-07-29 2000-07-18 Radiance Medical Systems, Inc. Self expandable tubular support
US5755781A (en) * 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents
US5755778A (en) * 1996-10-16 1998-05-26 Nitinol Medical Technologies, Inc. Anastomosis device
US5968009A (en) * 1997-01-29 1999-10-19 Baxter International Inc. Double lumen tubing design for catheter
US5855565A (en) * 1997-02-21 1999-01-05 Bar-Cohen; Yaniv Cardiovascular mechanically expanding catheter
US5911732A (en) * 1997-03-10 1999-06-15 Johnson & Johnson Interventional Systems, Co. Articulated expandable intraluminal stent
US5800495A (en) * 1997-03-27 1998-09-01 Sulzer Intermedics Inc. Endocardial lead assembly
US5957949A (en) * 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US6162245A (en) * 1997-05-07 2000-12-19 Iowa-India Investments Company Limited Stent valve and stent graft
US6149696A (en) * 1997-11-06 2000-11-21 Komag, Inc. Colloidal silica slurry for NiP plated disk polishing
US6033436A (en) * 1998-02-17 2000-03-07 Md3, Inc. Expandable stent
US5980570A (en) * 1998-03-27 1999-11-09 Sulzer Carbomedics Inc. System and method for implanting an expandable medical device into a body
US6241746B1 (en) * 1998-06-29 2001-06-05 Cordis Corporation Vascular filter convertible to a stent and method
US6165194A (en) * 1998-07-24 2000-12-26 Micrus Corporation Intravascular flow modifier and reinforcement device
US6102945A (en) * 1998-10-16 2000-08-15 Sulzer Carbomedics, Inc. Separable annuloplasty ring
US6328765B1 (en) * 1998-12-03 2001-12-11 Gore Enterprise Holdings, Inc. Methods and articles for regenerating living tissue
US6086599A (en) * 1999-02-08 2000-07-11 The Regents Of The University Of California Micro devices using shape memory polymer patches for mated connections
US6258117B1 (en) * 1999-04-15 2001-07-10 Mayo Foundation For Medical Education And Research Multi-section stent
US6187040B1 (en) * 1999-05-03 2001-02-13 John T. M. Wright Mitral and tricuspid annuloplasty rings
US6210432B1 (en) * 1999-06-29 2001-04-03 Jan Otto Solem Device and method for treatment of mitral insufficiency
US6537314B2 (en) * 2000-01-31 2003-03-25 Ev3 Santa Rosa, Inc. Percutaneous mitral annuloplasty and cardiac reinforcement
US6402781B1 (en) * 2000-01-31 2002-06-11 Mitralife Percutaneous mitral annuloplasty and cardiac reinforcement
US6648874B2 (en) * 2000-02-28 2003-11-18 Scimed Life Systems, Inc. Guide catheter with lubricious inner liner
US6585716B2 (en) * 2000-04-05 2003-07-01 Biocardia, Inc. Method of treating the heart
US6602288B1 (en) * 2000-10-05 2003-08-05 Edwards Lifesciences Corporation Minimally-invasive annuloplasty repair segment delivery template, system and method of use
US6524301B1 (en) * 2000-12-21 2003-02-25 Advanced Cardiovascular Systems, Inc. Guidewire with an intermediate variable stiffness section
US20020087173A1 (en) * 2000-12-28 2002-07-04 Alferness Clifton A. Mitral valve constricting device, system and method
US20020099431A1 (en) * 2001-01-22 2002-07-25 Armstrong Joseph R. Deployment system for intraluminal devices
US6656221B2 (en) * 2001-02-05 2003-12-02 Viacor, Inc. Method and apparatus for improving mitral valve function
US20030078654A1 (en) * 2001-08-14 2003-04-24 Taylor Daniel C. Method and apparatus for improving mitral valve function
US7052487B2 (en) * 2001-10-26 2006-05-30 Cohn William E Method and apparatus for reducing mitral regurgitation
US7241310B2 (en) * 2002-01-14 2007-07-10 Taylor Daniel C Method and apparatus for reducing mitral regurgitation
US20050222678A1 (en) * 2004-04-05 2005-10-06 Lashinski Randall T Remotely adjustable coronary sinus implant

Cited By (141)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8267852B2 (en) 1997-01-02 2012-09-18 Edwards Lifesciences, Llc Heart wall tension reduction apparatus and method
US8460173B2 (en) 1997-01-02 2013-06-11 Edwards Lifesciences, Llc Heart wall tension reduction apparatus and method
US7695425B2 (en) 1997-01-02 2010-04-13 Edwards Lifesciences Llc Heart wall tension reduction apparatus and method
US7883539B2 (en) 1997-01-02 2011-02-08 Edwards Lifesciences Llc Heart wall tension reduction apparatus and method
US8226711B2 (en) 1997-12-17 2012-07-24 Edwards Lifesciences, Llc Valve to myocardium tension members device and method
US8187323B2 (en) 1997-12-17 2012-05-29 Edwards Lifesciences, Llc Valve to myocardium tension members device and method
US20020029080A1 (en) * 1997-12-17 2002-03-07 Myocor, Inc. Valve to myocardium tension members device and method
US7722523B2 (en) 1998-07-29 2010-05-25 Edwards Lifesciences Llc Transventricular implant tools and devices
US6997951B2 (en) 1999-06-30 2006-02-14 Edwards Lifesciences Ag Method and device for treatment of mitral insufficiency
US8709074B2 (en) 1999-06-30 2014-04-29 Edwards Lifesciences Ag Method and device for treatment of mitral insufficiency
US20040039443A1 (en) * 1999-06-30 2004-02-26 Solem Jan Otto Method and device for treatment of mitral insufficiency
US20040138744A1 (en) * 2000-01-31 2004-07-15 Randall Lashinski Transluminal mitral annuloplasty with active anchoring
US20040153146A1 (en) * 2000-01-31 2004-08-05 Randall Lashinski Methods and apparatus for remodeling an extravascular tissue structure
US7695512B2 (en) 2000-01-31 2010-04-13 Edwards Lifesciences Ag Remotely activated mitral annuloplasty system and methods
US20040133220A1 (en) * 2000-01-31 2004-07-08 Randall Lashinski Adjustable transluminal annuloplasty system
US7931684B2 (en) * 2000-10-05 2011-04-26 Edwards Lifesciences Corporation Minimally-invasive annuloplasty repair segment delivery system
US20050171601A1 (en) * 2000-10-05 2005-08-04 Cosgrove Delos M. Minimally-invasive annuloplasty repair segment delivery system
US7766812B2 (en) 2000-10-06 2010-08-03 Edwards Lifesciences Llc Methods and devices for improving mitral valve function
US9198757B2 (en) 2000-10-06 2015-12-01 Edwards Lifesciences, Llc Methods and devices for improving mitral valve function
US7776053B2 (en) 2000-10-26 2010-08-17 Boston Scientific Scimed, Inc. Implantable valve system
US20040059411A1 (en) * 2000-10-26 2004-03-25 Strecker Ernst Peter Implantable valve system
US20050096740A1 (en) * 2001-01-30 2005-05-05 Edwards Lifesciences Ag Transluminal mitral annuloplasty
US7828843B2 (en) 2001-05-14 2010-11-09 Cardiac Dimensions, Inc. Mitral valve therapy device, system and method
US20050027351A1 (en) * 2001-05-14 2005-02-03 Cardiac Dimensions, Inc. A Washington Corporation Mitral valve regurgitation treatment device and method
US20050038507A1 (en) * 2001-05-14 2005-02-17 Alferness Clifton A. Mitral valve therapy device, system and method
US20050027353A1 (en) * 2001-05-14 2005-02-03 Alferness Clifton A. Mitral valve therapy device, system and method
US20050021121A1 (en) * 2001-11-01 2005-01-27 Cardiac Dimensions, Inc., A Delaware Corporation Adjustable height focal tissue deflector
US8439971B2 (en) 2001-11-01 2013-05-14 Cardiac Dimensions, Inc. Adjustable height focal tissue deflector
US20100100175A1 (en) * 2001-11-01 2010-04-22 David Reuter Adjustable Height Focal Tissue Deflector
US8172898B2 (en) 2001-12-05 2012-05-08 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20070055293A1 (en) * 2001-12-05 2007-03-08 Alferness Clifton A Device and method for modifying the shape of a body organ
US7674287B2 (en) 2001-12-05 2010-03-09 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20040010305A1 (en) * 2001-12-05 2004-01-15 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US7857846B2 (en) 2001-12-05 2010-12-28 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20060142854A1 (en) * 2001-12-05 2006-06-29 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US8506624B2 (en) 2002-01-09 2013-08-13 Edwards Lifesciences, Llc Devices and methods for heart valve treatment
US8070805B2 (en) 2002-01-09 2011-12-06 Edwards Lifesciences Llc Devices and methods for heart valve treatment
US7678145B2 (en) 2002-01-09 2010-03-16 Edwards Lifesciences Llc Devices and methods for heart valve treatment
US20050216077A1 (en) * 2002-01-30 2005-09-29 Mathis Mark L Fixed length anchor and pull mitral valve device and method
US20030236569A1 (en) * 2002-01-30 2003-12-25 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20050209690A1 (en) * 2002-01-30 2005-09-22 Mathis Mark L Body lumen shaping device with cardiac leads
US8974525B2 (en) 2002-01-30 2015-03-10 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US9320600B2 (en) 2002-01-30 2016-04-26 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US9597186B2 (en) 2002-01-30 2017-03-21 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US20030171776A1 (en) * 2002-03-06 2003-09-11 Cardiac Dimensions, Inc. Transvenous staples, assembly and method for mitral valve repair
US7682385B2 (en) 2002-04-03 2010-03-23 Boston Scientific Corporation Artificial valve
US20050149180A1 (en) * 2002-05-08 2005-07-07 Mathis Mark L. Body lumen device anchor, device and assembly
US20050149179A1 (en) * 2002-05-08 2005-07-07 Mathis Mark L. Body lumen device anchor, device and assembly
US9474608B2 (en) 2002-05-08 2016-10-25 Cardiac Dimensions Pty. Ltd. Body lumen device anchor, device and assembly
US8062358B2 (en) 2002-05-08 2011-11-22 Cardiac Dimensions, Inc. Body lumen device anchor, device and assembly
US7666224B2 (en) 2002-11-12 2010-02-23 Edwards Lifesciences Llc Devices and methods for heart valve treatment
US20110066234A1 (en) * 2002-12-05 2011-03-17 Gordon Lucas S Percutaneous Mitral Valve Annuloplasty Delivery System
US20050119673A1 (en) * 2002-12-05 2005-06-02 Gordon Lucas S. Percutaneous mitral valve annuloplasty device delivery method
US20080109059A1 (en) * 2002-12-05 2008-05-08 Cardiac Dimensions, Inc. Medical Device Delivery System
US8182529B2 (en) 2002-12-05 2012-05-22 Cardiac Dimensions, Inc. Percutaneous mitral valve annuloplasty device delivery method
US20050096666A1 (en) * 2002-12-05 2005-05-05 Gordon Lucas S. Percutaneous mitral valve annuloplasty delivery system
US8075608B2 (en) 2002-12-05 2011-12-13 Cardiac Dimensions, Inc. Medical device delivery system
US7837729B2 (en) 2002-12-05 2010-11-23 Cardiac Dimensions, Inc. Percutaneous mitral valve annuloplasty delivery system
US20060020335A1 (en) * 2002-12-26 2006-01-26 Leonard Kowalsky System and method to effect the mitral valve annulus of a heart
US6964683B2 (en) 2002-12-26 2005-11-15 Cardiac Dimensions, Inc. System and method to effect the mitral valve annulus of a heart
US7780627B2 (en) 2002-12-30 2010-08-24 Boston Scientific Scimed, Inc. Valve treatment catheter and methods
US20040127848A1 (en) * 2002-12-30 2004-07-01 Toby Freyman Valve treatment catheter and methods
US20100280602A1 (en) * 2003-02-03 2010-11-04 Cardiac Dimensions, Inc. Mitral Valve Device Using Conditioned Shape Memory Alloy
US20070135912A1 (en) * 2003-02-03 2007-06-14 Mathis Mark L Mitral valve device using conditioned shape memory alloy
US7758639B2 (en) 2003-02-03 2010-07-20 Cardiac Dimensions, Inc. Mitral valve device using conditioned shape memory alloy
US20040153147A1 (en) * 2003-02-03 2004-08-05 Cardiac Dimensions, Inc. Mitral valve device using conditioned shape memory alloy
US20040158321A1 (en) * 2003-02-12 2004-08-12 Cardiac Dimensions, Inc. Method of implanting a mitral valve therapy device
US20040254600A1 (en) * 2003-02-26 2004-12-16 David Zarbatany Methods and devices for endovascular mitral valve correction from the left coronary sinus
US20040186566A1 (en) * 2003-03-18 2004-09-23 Hindrichs Paul J. Body tissue remodeling methods and apparatus
US20060161169A1 (en) * 2003-05-02 2006-07-20 Cardiac Dimensions, Inc., A Delaware Corporation Device and method for modifying the shape of a body organ
US20080015407A1 (en) * 2003-05-02 2008-01-17 Mathis Mark L Device and Method for Modifying the Shape of a Body Organ
US20050010240A1 (en) * 2003-06-05 2005-01-13 Cardiac Dimensions Inc., A Washington Corporation Device and method for modifying the shape of a body organ
US7887582B2 (en) 2003-06-05 2011-02-15 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20060116758A1 (en) * 2003-06-05 2006-06-01 Gary Swinford Device, System and Method to Affect the Mitral Valve Annulus of a Heart
US20050085903A1 (en) * 2003-10-17 2005-04-21 Jan Lau Heart valve leaflet locator
US7004176B2 (en) 2003-10-17 2006-02-28 Edwards Lifesciences Ag Heart valve leaflet locator
US9301843B2 (en) 2003-12-19 2016-04-05 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7854761B2 (en) 2003-12-19 2010-12-21 Boston Scientific Scimed, Inc. Methods for venous valve replacement with a catheter
US20050137451A1 (en) * 2003-12-19 2005-06-23 Cardiac Dimensions, Inc. A Washington Corporation Tissue shaping device with integral connector and crimp
US7814635B2 (en) 2003-12-19 2010-10-19 Cardiac Dimensions, Inc. Method of making a tissue shaping device
US7794496B2 (en) 2003-12-19 2010-09-14 Cardiac Dimensions, Inc. Tissue shaping device with integral connector and crimp
US20050137450A1 (en) * 2003-12-19 2005-06-23 Cardiac Dimensions, Inc., A Washington Corporation Tapered connector for tissue shaping device
US20050137685A1 (en) * 2003-12-19 2005-06-23 Cardiac Dimensions, Inc., A Washington Corporation Reduced length tissue shaping device
US8721717B2 (en) 2003-12-19 2014-05-13 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US20060276891A1 (en) * 2003-12-19 2006-12-07 Gregory Nieminen Mitral Valve Annuloplasty Device with Twisted Anchor
US9526616B2 (en) 2003-12-19 2016-12-27 Cardiac Dimensions Pty. Ltd. Mitral valve annuloplasty device with twisted anchor
US8128681B2 (en) 2003-12-19 2012-03-06 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US20060191121A1 (en) * 2003-12-19 2006-08-31 Lucas Gordon Tissue Shaping Device with Integral Connector and Crimp
US7837728B2 (en) 2003-12-19 2010-11-23 Cardiac Dimensions, Inc. Reduced length tissue shaping device
US20050137449A1 (en) * 2003-12-19 2005-06-23 Cardiac Dimensions, Inc. Tissue shaping device with self-expanding anchors
US7993397B2 (en) 2004-04-05 2011-08-09 Edwards Lifesciences Ag Remotely adjustable coronary sinus implant
US20050222678A1 (en) * 2004-04-05 2005-10-06 Lashinski Randall T Remotely adjustable coronary sinus implant
US8002824B2 (en) 2004-09-02 2011-08-23 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
US8932349B2 (en) 2004-09-02 2015-01-13 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
US9918834B2 (en) 2004-09-02 2018-03-20 Boston Scientific Scimed, Inc. Cardiac valve, system and method
US8992605B2 (en) 2004-09-14 2015-03-31 Edwards Lifesciences Ag Device and method for reducing mitral valve regurgitation
US7806928B2 (en) 2004-12-09 2010-10-05 Edwards Lifesciences Corporation Diagnostic kit to assist with heart valve annulus adjustment
US20070168023A1 (en) * 2004-12-09 2007-07-19 Rowe Stanton J Diagnostic kit to assist with heart valve annulus adjustment
US20060129051A1 (en) * 2004-12-09 2006-06-15 Rowe Stanton J Diagnostic kit to assist with heart valve annulus adjustment
US20060167544A1 (en) * 2005-01-20 2006-07-27 Cardiac Dimensions, Inc. Tissue Shaping Device
US7854755B2 (en) 2005-02-01 2010-12-21 Boston Scientific Scimed, Inc. Vascular catheter, system, and method
US9622859B2 (en) 2005-02-01 2017-04-18 Boston Scientific Scimed, Inc. Filter system and method
US7878966B2 (en) 2005-02-04 2011-02-01 Boston Scientific Scimed, Inc. Ventricular assist and support device
US7780722B2 (en) 2005-02-07 2010-08-24 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7670368B2 (en) 2005-02-07 2010-03-02 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7867274B2 (en) 2005-02-23 2011-01-11 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US9370419B2 (en) 2005-02-23 2016-06-21 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US9808341B2 (en) 2005-02-23 2017-11-07 Boston Scientific Scimed Inc. Valve apparatus, system and method
US7722666B2 (en) 2005-04-15 2010-05-25 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US9861473B2 (en) 2005-04-15 2018-01-09 Boston Scientific Scimed Inc. Valve apparatus, system and method
US8512399B2 (en) 2005-04-15 2013-08-20 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US7357815B2 (en) 2005-04-21 2008-04-15 Micardia Corporation Dynamically adjustable implants and methods for reshaping tissue
US20060241747A1 (en) * 2005-04-21 2006-10-26 Emanuel Shaoulian Dynamically adjustable implants and methods for reshaping tissue
US9028542B2 (en) 2005-06-10 2015-05-12 Boston Scientific Scimed, Inc. Venous valve, system, and method
US8012198B2 (en) 2005-06-10 2011-09-06 Boston Scientific Scimed, Inc. Venous valve, system, and method
US9492277B2 (en) 2005-08-30 2016-11-15 Mayo Foundation For Medical Education And Research Soft body tissue remodeling methods and apparatus
US8672997B2 (en) 2005-09-21 2014-03-18 Boston Scientific Scimed, Inc. Valve with sinus
US9474609B2 (en) 2005-09-21 2016-10-25 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US7951189B2 (en) 2005-09-21 2011-05-31 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US8460365B2 (en) 2005-09-21 2013-06-11 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US7799038B2 (en) 2006-01-20 2010-09-21 Boston Scientific Scimed, Inc. Translumenal apparatus, system, and method
US20070239270A1 (en) * 2006-04-11 2007-10-11 Mathis Mark L Mitral Valve Annuloplasty Device with Vena Cava Anchor
US20070282375A1 (en) * 2006-05-03 2007-12-06 St. Jude Medical, Inc. Soft body tissue remodeling methods and apparatus
US9101338B2 (en) 2006-05-03 2015-08-11 Mayo Foundation For Medical Education And Research Soft body tissue remodeling methods and apparatus
US20080087608A1 (en) * 2006-10-10 2008-04-17 Multiphase Systems Integration Compact multiphase inline bulk water separation method and system for hydrocarbon production
US8133270B2 (en) 2007-01-08 2012-03-13 California Institute Of Technology In-situ formation of a valve
US8348999B2 (en) 2007-01-08 2013-01-08 California Institute Of Technology In-situ formation of a valve
US9421083B2 (en) 2007-02-05 2016-08-23 Boston Scientific Scimed Inc. Percutaneous valve, system and method
US7967853B2 (en) 2007-02-05 2011-06-28 Boston Scientific Scimed, Inc. Percutaneous valve, system and method
US8470023B2 (en) 2007-02-05 2013-06-25 Boston Scientific Scimed, Inc. Percutaneous valve, system, and method
US8828079B2 (en) 2007-07-26 2014-09-09 Boston Scientific Scimed, Inc. Circulatory valve, system and method
US8414641B2 (en) 2007-12-21 2013-04-09 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US7892276B2 (en) 2007-12-21 2011-02-22 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US8137394B2 (en) 2007-12-21 2012-03-20 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US8006594B2 (en) * 2008-08-11 2011-08-30 Cardiac Dimensions, Inc. Catheter cutting tool
US9668859B2 (en) 2011-08-05 2017-06-06 California Institute Of Technology Percutaneous heart valve delivery systems
EP2886084A1 (en) 2011-12-12 2015-06-24 David Alon Heart valve repair device
WO2013088327A1 (en) 2011-12-12 2013-06-20 David Alon Heart valve repair device
EP2881083A1 (en) 2011-12-12 2015-06-10 David Alon Heart valve repair device
US9744037B2 (en) 2013-03-15 2017-08-29 California Institute Of Technology Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves
WO2014195786A2 (en) 2013-06-06 2014-12-11 David Alon Heart valve repair and replacement

Also Published As

Publication number Publication date Type
WO2004002290A3 (en) 2004-06-17 application
US20070156235A1 (en) 2007-07-05 application
US7125420B2 (en) 2006-10-24 grant
US20040073302A1 (en) 2004-04-15 application
WO2004002290A2 (en) 2004-01-08 application

Similar Documents

Publication Publication Date Title
US7753922B2 (en) Devices and methods for cardiac annulus stabilization and treatment
US7381210B2 (en) Mitral valve repair system and method for use
US6978176B2 (en) Treatment for patient with congestive heart failure
US6960229B2 (en) Device and method for modifying the shape of a body organ
US6569198B1 (en) Mitral or tricuspid valve annuloplasty prosthetic device
US7527646B2 (en) Devices, systems, and methods for retaining a native heart valve leaflet
US7442207B2 (en) Device, system, and method for treating cardiac valve regurgitation
US6402781B1 (en) Percutaneous mitral annuloplasty and cardiac reinforcement
US20070093869A1 (en) Device, system, and method for contracting tissue in a mammalian body
US20070055293A1 (en) Device and method for modifying the shape of a body organ
US7311729B2 (en) Device and method for modifying the shape of a body organ
US20090276040A1 (en) Device and method for replacing mitral valve
US20110257633A1 (en) Magnetic docking system and method for the long term adjustment of an implantable device
US20030233022A1 (en) Devices and methods for heart valve treatment
US20040220654A1 (en) Device and method for modifying the shape of a body organ
US20060247763A1 (en) Coronary sinus approach for repair of mitral valve regurgitation
US20110071626A1 (en) Device and Method for the Surgical Treatment of Ischemic Mitral Regurgitation
US7077861B2 (en) Annuloplasty instrument
US20040260393A1 (en) Devices, systems, and methods for reshaping a heart valve annulus
US20070061010A1 (en) Device and method for reshaping mitral valve annulus
US20060129051A1 (en) Diagnostic kit to assist with heart valve annulus adjustment
US20060129236A1 (en) Annuloplasty ring for mitral valve prolapse
US20060184242A1 (en) Method and apparatus for percutaneous reduction of anterior-posterior diameter of mitral valve
US20020087173A1 (en) Mitral valve constricting device, system and method
US20070093857A1 (en) Devices and methods for treating mitral valve regurgitation